top of page

Orthobiologics Manufacturer: PRP, BMAC, SVF & Regenerative Technologies

2 days ago
5 min read

Orthobiologics are biologically derived materials and preparations used in musculoskeletal and regenerative medicine. Common orthobiologic technologies include platelet-rich plasma (PRP), platelet-rich fibrin (PRF), bone marrow aspirate concentrate (BMAC) and adipose tissue-derived preparations such as stromal vascular fraction (SVF). 

STR Biotechnologies is a medical device manufacturer focused on point-of-care regenerative medicine and orthobiologic preparation technologies, including PRP, BMAC, SVF, PRF and CGF systems.

What Are Orthobiologics?

Orthobiologics are biological materials used to support tissue repair and regeneration, particularly within orthopedics and musculoskeletal medicine.

The term covers several different biological approaches rather than one specific product.

Common orthobiologics include:

  • PRP – Platelet-Rich Plasma

  • PRF – Platelet-Rich Fibrin

  • BMA/BMAC – Bone Marrow Aspirate / Concentrate

  • SVF and adipose-derived preparations

  • Growth factors and other biologically derived materials

Scientific literature consistently places PRP, BMAC and adipose-derived preparations among the principal autologous orthobiologic approaches.

What Does an Orthobiologics Manufacturer Do?

An orthobiologics manufacturer develops technologies and medical devices used to collect, process, separate or prepare biological materials for point-of-care applications.

Unlike pharmaceutical manufacturing, many autologous orthobiologic workflows begin with biological material obtained from the patient, such as:

Peripheral Blood → PRP / PRF / CGF

Bone Marrow → BMA / BMAC

Adipose Tissue → SVF / Adipose-Derived Preparations

Therefore, orthobiologic manufacturing is not simply about producing a tube or disposable kit.

The complete system may involve:

Collection → Separation → Concentration → Processing → Standardization → Final Biological Preparation

This makes device design, processing methodology, sterility and reproducibility important considerations in orthobiologic technology.

Major Orthobiologic Technologies

PRP – Platelet-Rich Plasma

PRP is one of the most widely studied and used autologous orthobiologics. It is prepared from peripheral blood and concentrates platelets and associated biological mediators into a smaller plasma volume.

Different PRP systems can produce preparations with different platelet concentrations, leukocyte profiles, final volumes and cellular compositions.

For this reason, PRP standardization and preparation technology matter. 

STR develops several PRP preparation technologies, including HighCell®, Unique® PRP and S&M® PRP systems.

BMAC – Bone Marrow Aspirate Concentrate

BMAC is prepared from bone marrow aspirate and contains a heterogeneous mixture of nucleated cells, hematopoietic cells, stromal cells, platelets and signaling molecules.

Scientific literature recognizes BMAC as an important autologous orthobiologic while also emphasizing considerable variability in preparation and characterization protocols.

STR's STEMMEX® BMAC Kit is designed for point-of-care bone marrow concentrate preparation.

When evaluating BMAC technologies, important parameters include:

Cell Recovery → Total Cell Yield → Final Volume → Cellular Composition → Reproducibility

Therefore, cell concentration alone should not be used to characterize BMAC preparation efficiency.

SVF – Stromal Vascular Fraction

SVF is a heterogeneous cell-containing fraction derived from adipose tissue.

Different processing technologies may use enzymatic digestion or mechanical/non-enzymatic approaches. These methods can produce biologically different preparations, making characterization and standardized processing important. Current evidence also shows substantial variability in SVF processing protocols and clinical evidence.

LIPOSTEM® SVF Kit represents STR's non-enzymatic mechanical adipose tissue processing technology.

PRF and CGF Technologies

Platelet-derived orthobiologics extend beyond conventional PRP.

PRF (Platelet-Rich Fibrin) incorporates platelets within a fibrin-rich biological matrix, while CGF (Concentrated Growth Factor) represents another centrifugation-based platelet-derived preparation approach.

PRF is recognized in contemporary orthobiologic literature alongside PRP and other autologous biological preparations.

STR's orthobiologic portfolio includes PRF preparation technologies, GrowthCell® CGF and LABFUGE® centrifugation systems.

Why Point-of-Care Processing Matters

A major characteristic of autologous orthobiologics is that biological material can be collected and processed near the point of care.

This creates a need for preparation technologies that prioritize:

Controlled ProcessingProtocols should reduce unnecessary variability between preparations.

Closed-System DesignWhere applicable, closed processing can help limit unnecessary environmental exposure during preparation.

ReproducibilitySimilar processing conditions should produce reasonably consistent biological preparations.

CharacterizationCell concentration, recovery, final volume and biological composition should be clearly distinguished.

Scientific reviews repeatedly identify lack of standardized preparation and reporting as one of the major challenges facing orthobiologics.

STR Biotechnologies: Orthobiologic Preparation Technologies

STR Biotechnologies develops and manufactures medical devices and preparation systems focused on point-of-care regenerative medicine and orthobiologics.

The STR technology portfolio connects multiple biological sources within one regenerative medicine platform:

Blood → PRP / PRF / CGF

Bone Marrow → BMAC

Adipose Tissue → SVF

Platelets → Platelet-Derived Technologies

This integrated approach enables STR to develop technologies across several major areas of contemporary orthobiologics rather than focusing on a single biological preparation.

The portfolio includes HighCell®, Unique®, S&M® PRP, STEMMEX® BMAC, LIPOSTEM® SVF, GrowthCell® CGF and LABFUGE® technologies.

The Future of Orthobiologics

The future of orthobiologics will depend not only on new biological technologies but also on better standardization, characterization and reproducibility.

Current scientific guidelines emphasize that evidence varies considerably according to the biological product and clinical indication, while differences in preparation techniques, dosage and characterization remain important limitations.

For manufacturers, this means the next generation of orthobiologic systems should increasingly focus on:

Biological Understanding + Medical Device Engineering + Controlled Processing + Standardization

rather than simply increasing concentration values.

Conclusion

Orthobiologics represent a rapidly developing intersection between orthopedics, regenerative medicine and medical device technology.

PRP, BMAC, SVF, PRF and related biological preparations differ substantially in their biological source and processing requirements, but they share one fundamental need:

reliable and reproducible preparation technology.

STR Biotechnologies focuses on this point-of-care preparation layer by developing technologies across PRP, BMAC, SVF, PRF and CGF workflows.

Editor’s Note

This content has been prepared based on current scientific literature and international peer-reviewed publications. It is provided for informational purposes only and does not constitute diagnosis or treatment advice. Clinical decisions should always be made by qualified healthcare professionals.

Related STR Products

HighCell® PRP Kit — Platelet-rich plasma preparation technology.

Unique® PRP Kit — PRP preparation system designed around controlled blood component separation.

STEMMEX® BMAC Kit — Bone marrow aspirate concentrate preparation technology.

LIPOSTEM® SVF Kit — Non-enzymatic mechanical adipose tissue processing system.

GrowthCell® CGF Kit — Concentrated growth factor preparation technology.

LABFUGE® — Centrifugation platform for regenerative medicine preparation workflows.

Related Blog Articles

Cell Recovery in BMAC: Why Total Cell Yield Matters

Filtration-Free vs. Filter-Based BMAC Preparation: What Is the Difference?

SVF Cell Yield and Cell Viability: What Determines Isolation Efficiency?

Enzymatic vs. Non-Enzymatic SVF Isolation: What Is the Difference?

Buffy Coat in PRP: Why Is It Important?

Scientific References

  1. Pereira H, et al. Orthobiologics: a review. International Orthopaedics. 2023. PMID: 37071148.

  2. Evidence-based orthobiologic practice: Current evidence review and future directions. 2024. Reviews PRP, BMAC, SVF and other major orthobiologic approaches and highlights the continuing need for standardized protocols.

  3. Orthobiologics Revisited: A Concise Perspective on Regenerative Orthopedics. 2025. Reviews PRP, PRF, BMAC and adipose-derived orthobiologics.

  4. Platelet-rich plasma vs bone marrow aspirate concentrate: An overview of mechanisms of action and orthobiologic synergistic effects. 2021.

  5. Evidence-based guidelines on orthobiologics. Reviews current evidence and emphasizes variability in preparation, dosage, protocols and regulatory considerations.

FAQ

What is an orthobiologics manufacturer?

An orthobiologics manufacturer develops medical devices, preparation systems or biological technologies used in orthopedics and regenerative medicine, including technologies associated with PRP, BMAC and other biologic preparations.

What are the main types of orthobiologics?

Common orthobiologics include PRP, PRF, BMAC, adipose-derived preparations such as SVF, growth factors and several other biological materials.

Is PRP an orthobiologic?

Yes. PRP is one of the most widely recognized blood-derived autologous orthobiologics.

Is BMAC an orthobiologic?

Yes. BMAC is a bone marrow-derived autologous orthobiologic containing multiple cellular and molecular components.

Is SVF considered an orthobiologic?

SVF and related adipose-derived preparations are commonly discussed within contemporary orthobiologic and regenerative medicine literature.

What is point-of-care orthobiologic processing?

It refers broadly to workflows in which autologous biological material is collected and prepared near the clinical point of use rather than through extended external laboratory manufacturing.

STR Biotechnologies develops orthobiologic preparation technologies for PRP, BMAC, SVF, PRF and CGF with medical device manufacturing capabilities.

 
 
bottom of page